Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM)

NCT05962840 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

ANCA Associated Vasculitis

Interventions

DRUG: Telitacicept
OTHER: Placebo of Telitacicept

Sponsor

Chinese SLE Treatment And Research Group

Collaborators

[object Object]